GB0822171D0 - Temisartan formulations - Google Patents

Temisartan formulations

Info

Publication number
GB0822171D0
GB0822171D0 GB0822171A GB0822171A GB0822171D0 GB 0822171 D0 GB0822171 D0 GB 0822171D0 GB 0822171 A GB0822171 A GB 0822171A GB 0822171 A GB0822171 A GB 0822171A GB 0822171 D0 GB0822171 D0 GB 0822171D0
Authority
GB
United Kingdom
Prior art keywords
temisartan
formulations
temisartan formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0822171A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arrow International Ltd
Original Assignee
Arrow International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arrow International Ltd filed Critical Arrow International Ltd
Priority to GB0822171A priority Critical patent/GB0822171D0/en
Publication of GB0822171D0 publication Critical patent/GB0822171D0/en
Priority to PCT/GB2009/002793 priority patent/WO2010063997A1/en
Ceased legal-status Critical Current

Links

GB0822171A 2008-12-04 2008-12-04 Temisartan formulations Ceased GB0822171D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0822171A GB0822171D0 (en) 2008-12-04 2008-12-04 Temisartan formulations
PCT/GB2009/002793 WO2010063997A1 (en) 2008-12-04 2009-12-01 Telmisartan formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0822171A GB0822171D0 (en) 2008-12-04 2008-12-04 Temisartan formulations

Publications (1)

Publication Number Publication Date
GB0822171D0 true GB0822171D0 (en) 2009-01-14

Family

ID=40289507

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0822171A Ceased GB0822171D0 (en) 2008-12-04 2008-12-04 Temisartan formulations

Country Status (2)

Country Link
GB (1) GB0822171D0 (en)
WO (1) WO2010063997A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113116835A (en) * 2021-05-11 2021-07-16 南京双科医药开发有限公司 Preparation method of telmisartan tablets

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1157500A (en) * 1998-11-06 2000-05-29 Boehringer Ingelheim International Gmbh Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof
US9029363B2 (en) * 2003-04-30 2015-05-12 Boehringer Ingelheim International Gmbh Telmisartan sodium salt pharmaceutical formulation
DE102005016345A1 (en) * 2005-04-09 2006-10-12 Bayer Healthcare Ag New use of 2-phenyl-substituted imidazotriazinone derivatives
EP1970053A1 (en) * 2007-03-14 2008-09-17 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical composition
EP2203158A4 (en) * 2007-10-30 2012-12-26 Reddys Lab Ltd Dr Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
PL2252273T3 (en) * 2008-03-19 2017-07-31 Ratiopharm Gmbh Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
CZ301070B6 (en) * 2008-07-31 2009-10-29 Zentiva, A. S. Telmisartan tablets

Also Published As

Publication number Publication date
WO2010063997A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
ZA201106050B (en) Dye-polymers formulations
GB0711656D0 (en) Formulations
GB0716385D0 (en) Formulations
GB0823269D0 (en) Formulations
ZA200908969B (en) Formulations
GB0821789D0 (en) Formulations
GB0711957D0 (en) Formulations
GB0919210D0 (en) Formulations
GB0809979D0 (en) Formulations
HUE054030T2 (en) Improved formulations
EP2307021A4 (en) Formulations
GB0806978D0 (en) Novel formulations
GB0822633D0 (en) Formulation
GB0810232D0 (en) Formulations
ZA201004772B (en) Novel formulation
GB0814376D0 (en) Formulation
GB0705179D0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
IL217390A0 (en) Formulations
GB0823486D0 (en) Formulations
GB0916106D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)